Summary of Product Characteristics
last updated on the eMC:
27/04/2012
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 27/04/2012 and displayed until Current
|
Reasons for adding or updating:
|
-
Change to section 3 - Pharmaceutical form
-
Change to section 10 date of revision of the text
|
| Date of revision of text on the SPC: 01-Feb-2012 |
| Legal Category: POM |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
- In section 3 a description of the product has been added
- In section 10 the date of revision of the text has been updated
|
|
Updated on 15/10/2009 and displayed until 27/04/2012
|
Reasons for adding or updating:
|
-
Change to section 6. 4 - Special Precautions for Storage
|
| Date of revision of text on the SPC: 01-May-2009 |
| Legal Category: POM |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| In section 6.4 'Keep the ampoule in the outer carton in order to protect it from light' has been added.
|
|
Updated on 14/04/2009 and displayed until 15/10/2009
|
Reasons for adding or updating:
|
-
Change to section 4.2 - Posology and method of administration
-
Change to section 6. 3 - Shelf Life
-
Change to section 6. 4 - Special Precautions for Storage
-
Change to section 10 date of revision of the text
|
| Date of revision of text on the SPC: 01-Feb-2009 |
| Legal Category: POM |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
In section 4.2, Shake the ampoule for a minimum of 5 seconds before use has been added.
In section 6.3, the shalf life has been changed from 2 to 3 years.
In section 6.4, the special precautions have been changed to store at 2-8 degrees C.
|
|
Updated on 07/06/2007 and displayed until 14/04/2009
|
Reasons for adding or updating:
|
-
Change to section 4.3 - Contraindications
-
Change to section 4.4 - Special warnings and precautions for Use
-
Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
-
Change to section 4.6 - Pregnancy and Lactation
-
Change to section 4.7 - Effects on Ability to Drive and Use Machines
-
Change to section 4.8 - Undesirable Effects
-
Change to section 4.9 - Overdose
|
| Date of revision of text on the SPC: 10/2006 |
| Legal Category: POM |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
Sections 4.3, 4.4 and 4.7 inclusion of statements.
Sections 4.5, 4.6, 4.8 and 4.9 additional statements.
|
|
Updated on 02/12/2005 and displayed until 07/06/2007
|
Reasons for adding or updating:
|
|
|
|
Updated on 09/08/2001 and displayed until 02/12/2005
|
Reasons for adding or updating:
|
-
Transferred from eMC version 1
|
|
Updated on 08/02/2000 and displayed until 09/08/2001
|
Reasons for adding or updating:
|
|
|
|
Updated on 06/09/1999 and displayed until 08/02/2000
|
Reasons for adding or updating:
|
|
|
|